Stay updated on Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.

Latest updates to the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Study Details page revision was updated from v3.6.3 to v3.6.4, indicating a minor editorial update to the page. It does not change the underlying study content or user-facing information.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays a new revision label, updating from v3.6.2 to v3.6.3. This reflects a minor site version update rather than a change to the study details or content.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision label in the page footer updated from v3.6.0 to v3.6.2, indicating a software/UI update; the core study details and navigation remain unchanged.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now includes new sections to help readers interpret the study record and how to join, and it indicates that recruitment is closed ('No longer looking for participants'). The Intervention/Treatment header has been reformatted (Intervention/Treatment) and the page revision updated to v3.6.0.SummaryDifference0.2%

- Check64 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, representing a new version of the page. This appears to be a minor maintenance update rather than a change to the study content.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision: v3.5.4 appears as a software/version update for the page. This update is minor and does not alter the study details or displayed content.SummaryDifference0.0%

Stay in the know with updates to Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.